Grown Rogue International (GRUSF) Intangibles (2016 - 2026)
Grown Rogue International's (GRUSF) quarterly Intangibles came in at $3.0 million in Q1 2026, little changed quarter-over-quarter from $3.0 million in Q4 2025.
Grown Rogue International (GRUSF) Intangibles (2016 - 2026) Analysis & Trends
Grown Rogue International's Intangibles history runs 11 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- On a quarterly basis, Intangibles changed N/A year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $3.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $3.0 million, changed 0.0% from the prior year.
- Intangibles held at $3.0 million in Q1 2026 per GRUSF's latest filing, from $3.0 million in the prior quarter.
- Across five years, Intangibles topped out at $3.0 million in Q4 2024 and bottomed at $725668.0 in Q4 2022.
- The 5-year median for Intangibles is $1.9 million (2022), against an average of $1.9 million.
- Across the five-year window, Intangibles changed 0.0% in 2023 and soared 316.88% in 2024, its largest moves.
- Year by year, Intangibles stood at $725668.0 in 2022, then changed by 0.0% to $725668.0 in 2023, then soared by 316.88% to $3.0 million in 2024, then changed by 0.0% to $3.0 million in 2025, then changed by 0.0% to $3.0 million in 2026.
- Per Business Quant, the three latest GRUSF Intangibles figures stand at $3.0 million (Q1 2026), $3.0 million (Q4 2025), and $3.0 million (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | 3.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.03 Mn |
| Dec 31, 2025 | 3.03 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | 725,668.00 |
| Oct 31, 2023 | 725,668.00 |
| Oct 31, 2022 | 725,668.00 |
| Oct 31, 2021 | 399,338.00 |
| Oct 31, 2020 | 4,997.00 |
| Jul 31, 2020 | 13,977.00 |
| Apr 30, 2020 | 19,957.00 |
| Jan 31, 2020 | 26,938.00 |
| Oct 31, 2019 | 34,597.00 |
| Jul 31, 2019 | 79,259.00 |
| Apr 30, 2019 | 66,197.00 |
| Jan 31, 2019 | 66,117.00 |
| Oct 31, 2018 | 12,360.00 |
| Apr 30, 2018 | 77,048.00 |
| Oct 31, 2017 | 9,968.00 |
| May 31, 2016 | 7.32 Mn |
| Feb 29, 2016 | -6.86 Mn |